ifosfamide has been researched along with Cutaneous T-Cell Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dangien, A | 1 |
| Ram-Wolff, C | 1 |
| Brice, P | 1 |
| Battistella, M | 1 |
| Roelens, M | 1 |
| Moins-Teisserenc, H | 1 |
| Peffault de Latour, R | 1 |
| Mourah, S | 1 |
| Bouaziz, JD | 1 |
| Lebbé, C | 1 |
| Bagot, M | 1 |
| de Masson, A | 1 |
| Hosler, GA | 1 |
| Liégeois, N | 1 |
| Anhalt, GJ | 1 |
| Moresi, JM | 1 |
2 other studies available for ifosfamide and Cutaneous T-Cell Lymphoma
| Article | Year |
|---|---|
Ifosfamide and etoposide in advanced-stage, relapsed or refractory primary cutaneous T-cell lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Ifosfamide; Lymphoma, Non-Hodgkin | 2020 |
Transformation of cutaneous gamma/delta T-cell lymphoma following 15 years of indolent behavior.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Transformation, Neoplastic; Clone | 2008 |